Dr Ipshita Mandal-Johnson is building bio innovative-inclusive-impactful systems through venture investment, consulting and research.
Primarily, serving as Founding Partner & CEO of Global Bio Fund where she is focused on investing in and scaling women led bio ventures addressing human and planetary health. She is also a Principal Consultant at BioPacific Partners which is growing bio innovations from Australasia.
She currently serves on the advisory boards of Proximie, Chiasma NZ and Global Engineering Futures. She is a Judge on Mass Challenge and Women in Bio, and a member of the UNAIDS HIEx Investors Council. She is a Visiting Lecturer at the Harvard School of Public Health and University of Cambridge CEB.
She started her career in New Zealand and has since worked in the US, UK and India amongst others.
One of her career highlights was co-founding the Global Biotech Revolution / GapSummit – the world’s first inter-generational platform for the bio-economy. To date the summits have brought together 600 Leaders of Tomorrow from 72 countries to debate with 300 Leaders of Today, building 18 companies that have raised independent funding.
In addition, she has worked in McKinsey in the India and NY offices primarily worked in the technology, healthcare and public sector practices. She has led the development of Government of India’s “Digital India 2.0” strategy and was also the Chief of Staff for a M&A deal valued at over 50Bn USD.
Ipshita is also an advocate and speaker for bio and women’s leadership in global media and industry bodies such as Foreign Policy, UNAIDS Health Investors Coalition, Nasdaq, Nature Careers, The Economist Intelligence Unit, Women in Bio, Global BioEconomy Summit, Graduate Women in Science Lioness Magazine, Impact Alpha, BioScience Investors Inclusion Group, NZ Herald amongst others.
She has received multiple awards including thrice being listed in the 50 Movers and Shakers in Bio Business, St Gallen Leader of Tomorrow and an inaugural 40 under 40 for University of Auckland.Log in to view